Filing Details
- Accession Number:
- 0001209191-21-067244
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-01 13:15:08
- Reporting Period:
- 2021-11-29
- Accepted Time:
- 2021-12-01 13:15:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1160308 | Savara Inc | SVRA | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1283292 | A David Ramsay | 6836 Bee Cave Road Building Iii, Suite 201 Austin TX 78746 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-30 | 16,000 | $1.09 | 1,317,142 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-01 | 9,000 | $1.09 | 1,326,142 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The price is a weighted average purchase price. The purchase prices ranged from $1.08 to $1.10. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- The price is a weighted average purchase price. The purchase prices ranged from $1.08 to $1.105. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.